Selected experience includes:- defending Sprint Corp. in a lawsuit brought by state attorneys general challenging the proposed acquisition of Sprint by T-Mobile, which resulted in judgment for T-Mobile and Sprint;- defending Actavis, Inc. in a suit brought by the Federal Trade Commission (FTC), including before the U.S. Supreme Court, challenging the legality of a patent litigation settlement;- defending Actavis, Inc. and a Teva Pharmaceuticals U.S., Inc. affiliate in multidistrict “reverse-payment” class action litigation related to the brand-name drug AndroGel 1%;- defending Medicis Pharmaceutical Corp. in multidistrict “reverse-payment” class action litigation related to the acne product Solodyn;- representing Johnson-Matthey in a suit brought by Actelion Pharmaceuticals Ltd. against multiple prospective generic manufacturers involving monopolization and restraint of trade claims in connection with Actelion’s REMS and restricted pharmaceutical distribution programs;- representing brand-name and generic pharmaceutical companies in connection with FTC investigations and inquiries;- defending a pharmaceutical company CEO in a challenge to an FTC investigation;- defending Nokia in an antitrust challenge to its IP licensing practices by Apple;- defending Energy Transfer Partners in an antitrust class action alleging conspiracy and predatory pricing in the Texas natural gas market; and- representing a financial futures exchange during a U.S. Department of Justice (DOJ) investigation into a proposed joint venture.